Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2017

01-08-2017 | Original Article

Influence of Diet on the Course of Inflammatory Bowel Disease

Authors: Laura Tasson, Cristina Canova, Maria Grazia Vettorato, Edoardo Savarino, Renzo Zanotti

Published in: Digestive Diseases and Sciences | Issue 8/2017

Login to get access

Abstract

Background

While the importance of diet in the pathogenesis of inflammatory bowel disease (IBD) is generally recognized, influence of food on the course of IBD is little understood.

Aim

The purpose of this study was to assess the association between food intake and course of disease in patients with IBD.

Methods

We performed a cross-sectional study on 103 adult patients (50 with active disease and 53 in remission, divided by their calprotectin level), who completed a food frequency questionnaire on their intake of several foods over 1 year. Diet, as assessed using a 146-item self-administered food frequency questionnaire, was correlated with objective evidence of disease based on fecal calprotectin levels.

Results

Legumes and potato were inversely associated with disease relapse (p value for trend 0.023) with patients in the highest quartile for legume and potato consumption carrying a 79% lower risk of active disease (adjusted OR 0.21, 95% CI 0.57–0.81). A positive association emerged between meat intake and disease relapse, the highest quartile for meat consumption coinciding with a higher risk of active disease (OR 3.61, 95% CI 1.15–11.38), though this was not significant in the adjusted analysis. No statistically significant associations were found between disease relapse and the intake of vegetables, cereals, dairy products, or fish.

Conclusions

Our results suggest a potentially protective role of legumes and potato and a detrimental influence of meat in maintaining clinical remission in IBD patients. These findings have important public health implications, but further interventional studies will be needed to demonstrate these associations.
Literature
2.
go back to reference Bernstein CN, Eliakim A, Fedail S, et al. Inflammatory bowel disease. World Gastroenterol Global Guidelines. 2015;50:803–818. Bernstein CN, Eliakim A, Fedail S, et al. Inflammatory bowel disease. World Gastroenterol Global Guidelines. 2015;50:803–818.
3.
4.
go back to reference Wu GD, Bushmanc FD, Lewis JD. Diet, the human gut microbiota, and IBD. Anaerobe. 2013;24:117–120.CrossRefPubMed Wu GD, Bushmanc FD, Lewis JD. Diet, the human gut microbiota, and IBD. Anaerobe. 2013;24:117–120.CrossRefPubMed
5.
go back to reference Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol. 2016;22:1088–1100.CrossRefPubMedPubMedCentral Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol. 2016;22:1088–1100.CrossRefPubMedPubMedCentral
6.
7.
go back to reference Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77:57–64.CrossRefPubMed Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77:57–64.CrossRefPubMed
8.
go back to reference Levine A, Wine E. Effects of enteral nutrition on Crohn’s disease. Inflamm Bowel Dis. 2013;19:1322–1329.CrossRefPubMed Levine A, Wine E. Effects of enteral nutrition on Crohn’s disease. Inflamm Bowel Dis. 2013;19:1322–1329.CrossRefPubMed
10.
go back to reference Chiba M, Abe T, Tsuda H, et al. Lifestyle-related disease in Crohn’s disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol. 2010;16:2484–2495.CrossRefPubMedPubMedCentral Chiba M, Abe T, Tsuda H, et al. Lifestyle-related disease in Crohn’s disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol. 2010;16:2484–2495.CrossRefPubMedPubMedCentral
11.
go back to reference Faghfoori Z, Shakerhosseini R, Navai L, Somi MH, Nikniaz Z, Abadi A. Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis. Health Promot Perspect. 2014;4:116–121.PubMedPubMedCentral Faghfoori Z, Shakerhosseini R, Navai L, Somi MH, Nikniaz Z, Abadi A. Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis. Health Promot Perspect. 2014;4:116–121.PubMedPubMedCentral
12.
go back to reference Halmos EP. A low fodmap diet in patients with Crohn’s disease. J Gastroenterol Hepatol. 2016;31:14–15.CrossRefPubMed Halmos EP. A low fodmap diet in patients with Crohn’s disease. J Gastroenterol Hepatol. 2016;31:14–15.CrossRefPubMed
13.
go back to reference Cohen S, Gold BD, Oliva S, et al. Clinical and mucosal improvement with the specific carbohydrate diet in pediatric Crohn’s disease: a prospective pilot study. J Pediatr Gastroenterol Nutr. 2014;59:516–521. Cohen S, Gold BD, Oliva S, et al. Clinical and mucosal improvement with the specific carbohydrate diet in pediatric Crohn’s disease: a prospective pilot study. J Pediatr Gastroenterol Nutr. 2014;59:516–521.
14.
go back to reference Obih C, Wahbeh G, Lee D, et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2015;32:418–425.CrossRefPubMed Obih C, Wahbeh G, Lee D, et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2015;32:418–425.CrossRefPubMed
15.
go back to reference Lev-Tzion R, Griffiths A, Leder O. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2014. Lev-Tzion R, Griffiths A, Leder O. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2014.
16.
go back to reference Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Inflamm Bowel Dis. 2004;54:1479–1484. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Inflamm Bowel Dis. 2004;54:1479–1484.
17.
go back to reference Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 2010;61:219–225.CrossRefPubMed Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 2010;61:219–225.CrossRefPubMed
18.
go back to reference Mao R, Xiao YL, Gao X, et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. Inflamm Bowel Dis. 2012;18:1894–1899.CrossRefPubMed Mao R, Xiao YL, Gao X, et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. Inflamm Bowel Dis. 2012;18:1894–1899.CrossRefPubMed
19.
go back to reference Zittan E, Kelly OB, Kirsch R, et al. Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn’s disease. Inflamm Bowel Dis. 2016;23:1–8. Zittan E, Kelly OB, Kirsch R, et al. Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn’s disease. Inflamm Bowel Dis. 2016;23:1–8.
20.
go back to reference Lobatón T, López-García A, Rodríguez-Moranta F, Ruiz A, Rodríguez L, Guardiola J. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn’s disease. J Crohn’s Colitis. 2013;7:e641–e651.CrossRef Lobatón T, López-García A, Rodríguez-Moranta F, Ruiz A, Rodríguez L, Guardiola J. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn’s disease. J Crohn’s Colitis. 2013;7:e641–e651.CrossRef
21.
go back to reference Molander P, Färkkilä M, Ristimäki A, et al. Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission? J Crohns Colitis. 2015;9:33–40.PubMed Molander P, Färkkilä M, Ristimäki A, et al. Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission? J Crohns Colitis. 2015;9:33–40.PubMed
22.
go back to reference Yamaguchi S, Takeuchi Y, Arai K, et al. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis. J Gastroenterol Hepatol. 2015;1:93–98. Yamaguchi S, Takeuchi Y, Arai K, et al. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis. J Gastroenterol Hepatol. 2015;1:93–98.
23.
go back to reference Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European prospective investigation of cancer. Br J Cancer. 1999;80:95–103.PubMed Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European prospective investigation of cancer. Br J Cancer. 1999;80:95–103.PubMed
24.
go back to reference Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’ s disease: definitions and diagnosis. J Crohn’s Colitis. 2010;4:7–27.CrossRef Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’ s disease: definitions and diagnosis. J Crohn’s Colitis. 2010;4:7–27.CrossRef
25.
go back to reference Fantuzzi F, Chiunchiù M, Bedogni G. Atlante fotografico delle porzioni degli alimenti. Milano: Istituto Scotti Bassani; 2005. Fantuzzi F, Chiunchiù M, Bedogni G. Atlante fotografico delle porzioni degli alimenti. Milano: Istituto Scotti Bassani; 2005.
26.
go back to reference James SL, Christophersen CT, Bird AR, et al. Abnormal fibre usage in UC in remission. Gut. 2015;64:562–570.CrossRefPubMed James SL, Christophersen CT, Bird AR, et al. Abnormal fibre usage in UC in remission. Gut. 2015;64:562–570.CrossRefPubMed
27.
go back to reference McRorie JW. Evidence-based approach to fiber supplements and clinically meaningful health benefits, Part 2: what to look for and how to recommend an effective fiber therapy. Nutr Today. 2015;50:90–97.CrossRefPubMedPubMedCentral McRorie JW. Evidence-based approach to fiber supplements and clinically meaningful health benefits, Part 2: what to look for and how to recommend an effective fiber therapy. Nutr Today. 2015;50:90–97.CrossRefPubMedPubMedCentral
28.
go back to reference Sarbagili-Shabat C, Sigall-Boneah R, Levine A. Nutritional therapy in inflammatory bowel disease. Curr Opin Gastroenterol. 2015;31:303–308.CrossRefPubMed Sarbagili-Shabat C, Sigall-Boneah R, Levine A. Nutritional therapy in inflammatory bowel disease. Curr Opin Gastroenterol. 2015;31:303–308.CrossRefPubMed
29.
go back to reference Scaldaferri F, Gerardi V, Lopetuso LR, et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int. 2013;2013:435268.CrossRefPubMedPubMedCentral Scaldaferri F, Gerardi V, Lopetuso LR, et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int. 2013;2013:435268.CrossRefPubMedPubMedCentral
30.
go back to reference Verspreet J, Damen B, Broekaert WF, Verbeke K, Delcour JA, Courtin CM. A critical look at prebiotics within the dietary fiber concept. Annu Rev Food Sci Technol. 2016;7:annurev-food-081315-032749. Verspreet J, Damen B, Broekaert WF, Verbeke K, Delcour JA, Courtin CM. A critical look at prebiotics within the dietary fiber concept. Annu Rev Food Sci Technol. 2016;7:annurev-food-081315-032749.
31.
go back to reference Krumbeck JA, Maldonado-Gomez MX, Ramer-Tait AE, Hutkins RW. Prebiotics and synbiotics. Curr Opin Gastroenterol. 2016;32:110–119.CrossRefPubMed Krumbeck JA, Maldonado-Gomez MX, Ramer-Tait AE, Hutkins RW. Prebiotics and synbiotics. Curr Opin Gastroenterol. 2016;32:110–119.CrossRefPubMed
32.
go back to reference Johnson CR, Thavarajah D, Combs GF, Thavarajah P. Lentil (Lens culinaris L.): a prebiotic-rich whole food legume. Food Res Int. 2013;51:107–113.CrossRef Johnson CR, Thavarajah D, Combs GF, Thavarajah P. Lentil (Lens culinaris L.): a prebiotic-rich whole food legume. Food Res Int. 2013;51:107–113.CrossRef
33.
go back to reference Johnson CR, Thavarajah D, Thavarajah P, Payne S, Moore J, Ohm JB. Processing, cooking, and cooling affect prebiotic concentrations in lentil (Lens culinaris Medikus). J Food Compos Anal. 2015;38:106–111.CrossRef Johnson CR, Thavarajah D, Thavarajah P, Payne S, Moore J, Ohm JB. Processing, cooking, and cooling affect prebiotic concentrations in lentil (Lens culinaris Medikus). J Food Compos Anal. 2015;38:106–111.CrossRef
34.
go back to reference Kutoš T, Golob T, Kač M, Plestenjak A. Dietary fibre content of dry and processed beans. Food Chem. 2003;80:231–235.CrossRef Kutoš T, Golob T, Kač M, Plestenjak A. Dietary fibre content of dry and processed beans. Food Chem. 2003;80:231–235.CrossRef
35.
go back to reference Dwivedi S, Sahrawat K, Puppala N, Ortiz R. Plant prebiotics and human health: biotechnology to breed prebiotic-rich nutritious food crops. Electron J Biotechnol. 2014;17:238–245.CrossRef Dwivedi S, Sahrawat K, Puppala N, Ortiz R. Plant prebiotics and human health: biotechnology to breed prebiotic-rich nutritious food crops. Electron J Biotechnol. 2014;17:238–245.CrossRef
36.
go back to reference Zheng Y, Wang Q, Li B, et al. Characterization and prebiotic effect of the resistant starch from purple sweet potato. Molecules. 2016;21:932.CrossRef Zheng Y, Wang Q, Li B, et al. Characterization and prebiotic effect of the resistant starch from purple sweet potato. Molecules. 2016;21:932.CrossRef
37.
go back to reference Fuentes-Zaragoza E, Sánchez-Zapata E, Sendra E, et al. Resistant starch as prebiotic: a review. Starch/Staerke. 2011;63:406–415.CrossRef Fuentes-Zaragoza E, Sánchez-Zapata E, Sendra E, et al. Resistant starch as prebiotic: a review. Starch/Staerke. 2011;63:406–415.CrossRef
38.
go back to reference Deschasaux M, Pouchieu C, His M, Hercberg S, Latino-martel P, Touvier M. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer. J Nutr. 2014;144:504–510.CrossRefPubMed Deschasaux M, Pouchieu C, His M, Hercberg S, Latino-martel P, Touvier M. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer. J Nutr. 2014;144:504–510.CrossRefPubMed
39.
go back to reference Di Bartolomeo F, Startek JB, Van Den Ende W. Prebiotics to fight diseases: reality or fiction? Phyther Res. 2013;27:1457–1473. Di Bartolomeo F, Startek JB, Van Den Ende W. Prebiotics to fight diseases: reality or fiction? Phyther Res. 2013;27:1457–1473.
40.
go back to reference Franco-Robles E, Lopez MG. Implication of fructans in health: immunomodulatory and antioxidant mechanisms. Sci World J. 2015;2015:289267.CrossRef Franco-Robles E, Lopez MG. Implication of fructans in health: immunomodulatory and antioxidant mechanisms. Sci World J. 2015;2015:289267.CrossRef
41.
go back to reference Verspreet J, Holmgaard Hansen A, Dornez E, et al. LC-MS analysis reveals the presence of graminan- and neo-type fructans in wheat grains. J Cereal Sci. 2015;61:133–138.CrossRef Verspreet J, Holmgaard Hansen A, Dornez E, et al. LC-MS analysis reveals the presence of graminan- and neo-type fructans in wheat grains. J Cereal Sci. 2015;61:133–138.CrossRef
42.
go back to reference Peshev D, Van den Ende W. Fructans: prebiotics and immunomodulators. J Funct Foods. 2014;8:348–357.CrossRef Peshev D, Van den Ende W. Fructans: prebiotics and immunomodulators. J Funct Foods. 2014;8:348–357.CrossRef
43.
go back to reference Verspreet J, Dornez E, van den Ende W, Delcour JA, Courtin CM. Cereal grain fructans: structure, variability and potential health effects. Trends Food Sci Technol. 2015;43:32–42.CrossRef Verspreet J, Dornez E, van den Ende W, Delcour JA, Courtin CM. Cereal grain fructans: structure, variability and potential health effects. Trends Food Sci Technol. 2015;43:32–42.CrossRef
44.
go back to reference Dahl WJ, Ford AL, Ukhanova M, et al. Resistant potato starches (type 4 RS) exhibit varying effects on laxation with and without phylum level changes in microbiota: a randomised trial in young adults. J Funct Foods. 2016;23:1–11.CrossRef Dahl WJ, Ford AL, Ukhanova M, et al. Resistant potato starches (type 4 RS) exhibit varying effects on laxation with and without phylum level changes in microbiota: a randomised trial in young adults. J Funct Foods. 2016;23:1–11.CrossRef
45.
go back to reference Khodaei N, Karboune S. Enzymatic generation of galactose-rich oligosaccharides/oligomers from potato rhamnogalacturonan i pectic polysaccharides. Food Chem. 2016;197:406–414.CrossRefPubMed Khodaei N, Karboune S. Enzymatic generation of galactose-rich oligosaccharides/oligomers from potato rhamnogalacturonan i pectic polysaccharides. Food Chem. 2016;197:406–414.CrossRefPubMed
46.
go back to reference Verspreet J, Hemdane S, Dornez E, Cuyvers S, Delcour JA, Courtin CM. Maximizing the concentrations of wheat grain fructans in bread by exploring strategies to prevent their yeast (Saccharomyces cerevisiae)-mediated degradation. J Agric Food Chem. 2013;61:1397–1404.CrossRefPubMed Verspreet J, Hemdane S, Dornez E, Cuyvers S, Delcour JA, Courtin CM. Maximizing the concentrations of wheat grain fructans in bread by exploring strategies to prevent their yeast (Saccharomyces cerevisiae)-mediated degradation. J Agric Food Chem. 2013;61:1397–1404.CrossRefPubMed
48.
go back to reference Walton M, Alaunyte I. Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study. Br J Nutr. 2014;112:1628–1635.CrossRefPubMed Walton M, Alaunyte I. Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study. Br J Nutr. 2014;112:1628–1635.CrossRefPubMed
49.
go back to reference Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2016;55:897–906.CrossRefPubMed Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2016;55:897–906.CrossRefPubMed
50.
go back to reference Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease: a pilot study. J Crohn’s Colitis. 2009;3:8–14.CrossRef Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease: a pilot study. J Crohn’s Colitis. 2009;3:8–14.CrossRef
51.
go back to reference Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1.CrossRef Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1.CrossRef
52.
go back to reference Wedlake L, Slack N, Andreyev HJN, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20:576–586.CrossRefPubMed Wedlake L, Slack N, Andreyev HJN, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20:576–586.CrossRefPubMed
53.
go back to reference Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2015;65:1–10. Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2015;65:1–10.
54.
go back to reference Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013;19:650–661.CrossRefPubMed Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013;19:650–661.CrossRefPubMed
55.
go back to reference Windey K, de Preter V, Verbeke K. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2012;56:184–196.CrossRefPubMed Windey K, de Preter V, Verbeke K. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2012;56:184–196.CrossRefPubMed
56.
go back to reference Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009;58:1606–1611.CrossRefPubMed Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009;58:1606–1611.CrossRefPubMed
58.
go back to reference Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;22:1. Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;22:1.
59.
go back to reference Brasil Lopes M, Rocha R, Castro Lyra A, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29:575–581.PubMed Brasil Lopes M, Rocha R, Castro Lyra A, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29:575–581.PubMed
60.
go back to reference Szilagyi A, Galiatsatos P, Xue X. Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 2015;15:67.CrossRef Szilagyi A, Galiatsatos P, Xue X. Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 2015;15:67.CrossRef
61.
go back to reference Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol. 2007;149:470–479.CrossRefPubMedPubMedCentral Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol. 2007;149:470–479.CrossRefPubMedPubMedCentral
62.
go back to reference Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014;20:21–35.CrossRefPubMed Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014;20:21–35.CrossRefPubMed
Metadata
Title
Influence of Diet on the Course of Inflammatory Bowel Disease
Authors
Laura Tasson
Cristina Canova
Maria Grazia Vettorato
Edoardo Savarino
Renzo Zanotti
Publication date
01-08-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4620-0

Other articles of this Issue 8/2017

Digestive Diseases and Sciences 8/2017 Go to the issue